Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04845945 · ClinicalTrials.gov registry record
MISP 60528 Pneumococcal Vaccination
A clinical trial, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- 4
- Enrollment target
NCT04845945: Clinical Trial study, sponsored by Montefiore Medical Center.
NCT04845945 is a clinical trial that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04845945 was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study aims to use two different blood tests (ELISA and OPA) to study response to pneumococcal vaccination administered as per standard guidelines in patients who are undergoing workup for heart transplant (whether or not they have undergone LVAD implantation or have undergone heart transplant.
Primary Outcome
Antibody levels
Interventions
- BIOLOGICAL PCV15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-06-10 |
| Est. Completion | 2024-08-24 |
Why NCT04845945 stopped before completion
NCT04845945 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PCV15 is the first listed.
NCT04845945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04845945 about?
NCT04845945 is a clinical study titled "MISP 60528 Pneumococcal Vaccination". This study aims to use two different blood tests (ELISA and OPA) to study response to pneumococcal vaccination administered as per standard guidelines in patients who are undergoing workup for heart transplant (whether or not they have undergone LVAD implantation or have undergone heart transplant.
What is the current status of trial NCT04845945?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2021-06-10. Estimated completion is 2024-08-24.
What interventions are being tested in trial NCT04845945?
The interventions under investigation include: PCV15 (BIOLOGICAL).
Who is sponsoring clinical trial NCT04845945?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI